Literature DB >> 16145122

Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA.

Philippe Seksik1, Patricia Lepage, Marie-France de la Cochetière, Arnaud Bourreille, Malène Sutren, Jean-Paul Galmiche, Joël Doré, Philippe Marteau.   

Abstract

The mucosa-associated microbiota lining the gut epithelium might play a central role in the activation and/or perpetuation of mucosal inflammation in Crohn's disease (CD). We sought for localized dysbiosis by comparing the biodiversity and composition of the microbiotas in ulcerated and nonulcerated mucosal samples from patients with CD. Biopsy samples (n = 75) of ulcerated and adjacent nonulcerated mucosa were collected during colonoscopy from 15 patients, from the ileum, right colon, left colon, and rectum. Temporal temperature gradient gel electrophoresis (TTGE) of bacterial 16S rRNAs was used to evaluate the dominant bacterial species. TTGE profiles were compared using software that calculates similarity percentages. For a given patient, average similarity indexes between ulcerated and nonulcerated mucosal TTGE profiles ranged from 95.2% +/- 4.2% to 97.9% +/- 1.7% (means +/- standard deviations) for the different segments. The mean values did not differ significantly. Average interindividual similarity indexes for a given segment among the different patients ranged from 33.6% +/- 15.5% to 42.0% +/- 25.6%. In CD, the dominant microbiotas do not differ qualitatively between ulcerated and nonulcerated mucosae. Biodiversity remains high in ulcerated mucosa. This argues against a pathogenic role of localized qualitative dysbiosis in CD-associated ulceration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145122      PMCID: PMC1234104          DOI: 10.1128/JCM.43.9.4654-4658.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization.

Authors:  A Sghir; G Gramet; A Suau; V Rochet; P Pochart; J Dore
Journal:  Appl Environ Microbiol       Date:  2000-05       Impact factor: 4.792

2.  Molecular biological methods for studying the gut microbiota: the EU human gut flora project.

Authors:  M Blaut; M D Collins; G W Welling; J Doré; J van Loo; W de Vos
Journal:  Br J Nutr       Date:  2002-05       Impact factor: 3.718

3.  Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.

Authors:  A Suau; R Bonnet; M Sutren; J J Godon; G R Gibson; M D Collins; J Doré
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

4.  The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls.

Authors:  C Schultsz; F M Van Den Berg; F W Ten Kate; G N Tytgat; J Dankert
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

5.  Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.

Authors:  Maria Mylonaki; Neil B Rayment; David S Rampton; Barry N Hudspith; Jonathan Brostoff
Journal:  Inflamm Bowel Dis       Date:  2005-05       Impact factor: 5.325

6.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

7.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls.

Authors:  Wangxue Chen; Dong Li; Ian Wilson; Vinton S Chadwick
Journal:  J Gastroenterol Hepatol       Date:  2002-09       Impact factor: 4.029

9.  Gnotobiotic rats harboring human intestinal microbiota as a model for studying cholesterol-to-coprostanol conversion.

Authors:  Philippe Gérard; Fabienne Béguet; Pascale Lepercq; Lionel Rigottier-Gois; Violaine Rochet; Claude Andrieux; Catherine Juste
Journal:  FEMS Microbiol Ecol       Date:  2004-03-01       Impact factor: 4.194

10.  Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces.

Authors:  Erwin G Zoetendal; Atte von Wright; Terttu Vilpponen-Salmela; Kaouther Ben-Amor; Antoon D L Akkermans; Willem M de Vos
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

View more
  27 in total

1.  Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge.

Authors:  M F De La Cochetière; T Durand; P Lepage; A Bourreille; J P Galmiche; J Doré
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis.

Authors:  H Sokol; P Lepage; Ph Seksik; J Doré; Ph Marteau
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

3.  Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis.

Authors:  Uri Gophna; Katrin Sommerfeld; Sharon Gophna; W Ford Doolittle; Sander J O Veldhuyzen van Zanten
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

4.  Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.

Authors:  Pauline D Scanlan; Fergus Shanahan; Caitlin O'Mahony; Julian R Marchesi
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

5.  Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease.

Authors:  Krzysztof Fyderek; Magdalena Strus; Kinga Kowalska-Duplaga; Tomasz Gosiewski; Andrzej Wedrychowicz; Urszula Jedynak-Wasowicz; Małgorzata Sładek; Stanisław Pieczarkowski; Paweł Adamski; Piotr Kochan; Piotr B Heczko
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

6.  Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.

Authors:  Harry Sokol; Nadia Vasquez; Nadia Hoyeau-Idrissi; Philippe Seksik; Laurent Beaugerie; Anne Lavergne-Slove; Philippe Pochart; Philippe Marteau
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

Review 7.  Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease.

Authors:  Lulu Sun; Gerardo M Nava; Thaddeus S Stappenbeck
Journal:  Curr Opin Gastroenterol       Date:  2011-07       Impact factor: 3.287

8.  Molecular characterisation of the faecal microbiota in patients with type II diabetes.

Authors:  Xiaokang Wu; Chaofeng Ma; Lei Han; Muhammad Nawaz; Fei Gao; Xuyan Zhang; Pengbo Yu; Chang'an Zhao; Lianchuan Li; Aiping Zhou; Juan Wang; John E Moore; B Cherie Millar; Jiru Xu
Journal:  Curr Microbiol       Date:  2010-01-20       Impact factor: 2.188

9.  A distinctive 'microbial signature' in celiac pediatric patients.

Authors:  Serena Schippa; Valerio Iebba; Maria Barbato; Giovanni Di Nardo; Valentina Totino; Monica Proietti Checchi; Catia Longhi; Giulia Maiella; Salvatore Cucchiara; Maria Pia Conte
Journal:  BMC Microbiol       Date:  2010-06-17       Impact factor: 3.605

10.  Application of sequence-dependent electrophoresis fingerprinting in exploring biodiversity and population dynamics of human intestinal microbiota: what can be revealed?

Authors:  Geert Huys; Tom Vanhoutte; Peter Vandamme
Journal:  Interdiscip Perspect Infect Dis       Date:  2008-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.